1
Clinical Trials associated with Anti-CD7 CAR-T cells(Shanghai First People's Hospital)The Safety and Clinical Efficacy of Human CD7 CAR-T Cell Therapy for Patients With Relapsed/Refractory CD7 Positive T Cell Hematological Maliganacies
The purpose of this study is to evaluate the safety and efficacy of CAR T cell treatment targeting CD7 in patients with relapsed or refractory CD7 positive T-cell hematological maliganacies
100 Clinical Results associated with Anti-CD7 CAR-T cells(Shanghai First People's Hospital)
100 Translational Medicine associated with Anti-CD7 CAR-T cells(Shanghai First People's Hospital)
100 Patents (Medical) associated with Anti-CD7 CAR-T cells(Shanghai First People's Hospital)
100 Deals associated with Anti-CD7 CAR-T cells(Shanghai First People's Hospital)